Moleculin Biotech, Inc. (NASDAQ: MBRX) experienced a dramatic surge in its stock value following positive regulatory developments. As of the latest market check, MBRX shares
During previous trading session, the stock price of Moleculin Biotech, Inc. (NASDAQ: MBRX) saw a notable uptick, rising 23.11% to close at $3.09. This encouraging
Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-market trading after reporting that Praxis Genomics, LLC received accreditation from the College of
BlackBerry Limited (BB) stock soared 21.29% to $8.49 in the pre-market trading following the announcement of its multi-year, global agreement with Amazon Web Services, Inc.
Moleculin Biotech, Inc., (Nasdaq: MBRX) surged 43.59% in the pre-market session after, a clinical-stage pharmaceutical corporation with a wide pipeline of drug candidates targeting highly
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.